Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Allen & Hanburys Ltd
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 03/01/2012
SPC Ventolin Accuhaler

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 10 date of revision of the text
Updated on 21/07/2009 and displayed until 03/01/2012
Reasons for adding or updating:
  • Change to section 4.9 - Overdose
Updated on 11/07/2007 and displayed until 21/07/2009
Reasons for adding or updating:
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 date of revision of the text
Updated on 19/04/2006 and displayed until 11/07/2007
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 (date of (partial) revision of the text
Updated on 25/09/2003 and displayed until 19/04/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 25/09/2003 and displayed until 25/09/2003
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 19/09/2003 and displayed until 25/09/2003
Reasons for adding or updating:
  • Change to section 4.3 - Contra-indications
  • Change to section 6.1 - List of Excipients
Updated on 02/08/2001 and displayed until 19/09/2003
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 06/09/1999 and displayed until 02/08/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  salbutamol sulphate